951231-87-1 Usage
Explanation
The molecular formula represents the number of atoms of each element present in the compound.
Explanation
It is an organic compound because it contains carbon and hydrogen atoms.
Explanation
The compound is derived from benzene, with additional functional groups attached to the benzene ring.
Explanation
These functional groups are attached to the benzene ring, giving the compound its unique properties and reactivity.
Explanation
The compound is used as an intermediate in the synthesis of various organic compounds, which are then used in the production of pharmaceuticals, agrochemicals, and specialty chemicals.
Explanation
The compound is not highly reactive, but it is reactive enough to be used as an intermediate in the synthesis of other organic compounds.
Explanation
The compound can be used as a starting material to synthesize other substituted benzene derivatives with different functional groups attached to the benzene ring.
Type of compound
Organic compound
Structure
Substituted benzene derivative
Functional groups
Bromine atom, methoxy group, nitro group, and trifluoromethyl group
Applications
Building block for pharmaceuticals, agrochemicals, and specialty chemicals
Reactivity
Moderate level of reactivity
Use as a starting material
Synthesis of other substituted benzene derivatives
Check Digit Verification of cas no
The CAS Registry Mumber 951231-87-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,2,3 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 951231-87:
(8*9)+(7*5)+(6*1)+(5*2)+(4*3)+(3*1)+(2*8)+(1*7)=161
161 % 10 = 1
So 951231-87-1 is a valid CAS Registry Number.
951231-87-1Relevant articles and documents
PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGIUR2 ANTAGONISTS
-
Page/Page column 39, (2010/11/29)
The present invention relates to compounds of formula (I), a process for the manufacture thereof, pharmaceutical compositions containing them, and their use for treating CNS disorders:wherein A, B, X, Y, R1, R2, R3 and R4 are as defined in the description and claims.
